Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 6;2014(3):CD002890.
doi: 10.1002/14651858.CD002890.pub2.

Psychological therapies for thalassaemia

Kofi A Anie  1 , Pia Massaglia
Affiliations

Psychological therapies for thalassaemia

Kofi A Anie et al. Cochrane Database Syst Rev. .

Abstract

Background: Thalassaemia is a group of genetic blood disorders characterised by the absence or reduction in the production of haemoglobin. Severity is variable from less severe anaemia, through thalassaemia intermedia, to profound severe anaemia (thalassaemia major). In thalassaemia major other complications include growth retardation, bone deformation, and enlarged spleen. Blood transfusion is required to treat severe forms of thalassaemia, but this results in excessive accumulation of iron in the body (iron overload), removed mostly by a drug called desferrioxamine through 'chelation therapy'. Non-routine treatments are bone marrow transplantation (which is age restricted), and possibly hydroxyurea, designed to raise foetal haemoglobin level, thus reducing anaemia. In addition, psychological therapies seem appropriate to improving outcome and adherence to medical treatment.

Objectives: To examine the evidence that in people with thalassaemia, psychological treatments improve the ability to cope with the condition, and improve both medical and psychosocial outcomes.

Search methods: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Haemoglobinopathies Trials Register which comprises of references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings. Searches on the Internet were also performed.Date of the most recent search of the Group's Haemoglobinopathies Trials Register: 11 November 2013.

Selection criteria: All randomised or quasi-randomised controlled trials comparing the use of psychological intervention to no (psychological) intervention in people with thalassaemia.

Data collection and analysis: No trials of psychological therapies have been found in the literature for inclusion in this review.

Main results: There are currently no results to be reported.

Authors' conclusions: As a chronic disease with a considerable role for self-management, psychological support seems appropriate for managing thalassaemia. However, from the information currently available, no conclusions can be made about the use of specific psychological therapies in thalassaemia. This systematic review has clearly identified the need for well-designed, adequately-powered, multicentre, randomised controlled trials assessing the effectiveness of specific psychological interventions for thalassaemia.

PubMed Disclaimer

Conflict of interest statement

None known.

Update of

References

References to studies excluded from this review

Treadwell 2001 {published data only}
    1. Treadwell MJ, Weissman L. Improving adherence with deferoxamine regimens for patients receiving chronic transfusion therapy. Seminars in Hematology 2001;38(Suppl 1):77‐84. - PubMed

Additional references

Arruda 1997
    1. Arruda VR, Lima CS, Saad ST, Costa FF. Successful use of hydroxyurea in beta thalassemia major [letter]. New England Journal of Medicine 1997;336(13):964. - PubMed
Bland 2004
    1. Bland JM. Cluster randomised trials in the medical literature: two bibliometric surveys. BMC Medical Research Methodology 2004;4:21. - PMC - PubMed
Brittenham 1994
    1. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. New England Journal of Medicine 1994;331(9):567‐73. - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Lucarelli 1993
    1. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. New England Journal of Medicine 1993;329(12):840‐4. - PubMed
Masera 1990
    1. Masera G, Monguzzi G, Tornotti B, Lo lacono, Pertici S, Spinetta J. Psychosocial support in thalassaemia major: Monza center's experience. Supplemento Di Haematologia 1990;75(5):181‐90. - PubMed
Massaglia 1985
    1. Massaglia P, Carpignano M. Psychology of the patient and his family. 2nd Mediterranean meeting on thalassaemia, Milan, November 1985. In: Sirchia G, Zanella A editor(s). Thalassaemia today. The mediterranean experience. Milan: C.T.O.M.P., 1987:69‐79.
Modell 2000
    1. Modell B, Khan M, Darlison M. Survival in ß‐thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2000;355(9220):2051. - PubMed
Olivieri 1995
    1. Olivieri NF, Brittenham GM, Matsui D, Berkovitch M, Blandis LM, Cameron RG, et al. Iron‐chelation therapy with oral deferiprone in patients with thalassemia major. New England Journal of Medicine 1995;332(14):918‐22. - PubMed
Ratip 1995
    1. Ratip S, Skuse D, Porter J, Wonke B, Yardumian A, Model B. Psychosocial and clinical burden of thalassaemia intermedia and its implications for prenatal diagnosis. Archives of Disease in Childhood 1995;72(5):408‐12. - PMC - PubMed
Weatherall 1997
    1. Weatherall DJ. Fortnightly review: The thalassaemias. BMJ 1997;314(7095):1675‐8. - PMC - PubMed
WHO 1994
    1. WHO Working Group on Haemoglobinopathies. Guidelines for the control of haemoglobin disorders. World Health Organisation, Hereditary Diseases Programme. WHO, 1994.

References to other published versions of this review

Anie 2001
    1. Anie KA, Massaglia P. Psychological therapies for thalassaemia. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD002890] - DOI - PubMed

Publication types

Substances

LinkOut - more resources